KET‐MCI: An open‐label trial of single‐dose ketamine treatment to improve depression in mild cognitive impairment.
Title: | KET‐MCI: An open‐label trial of single‐dose ketamine treatment to improve depression in mild cognitive impairment. |
---|---|
Authors: | Fremont, Rachel, Karim, Amelia, Feder, Adriana, Naasan, Georges, Murrough, James, Berman, Julia |
Source: | Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2024 Supplement 8, Vol. 20 Issue S8, p1-1, 1p |
Database: | Complementary Index |
ISSN: | 15525260 |
---|---|
DOI: | 10.1002/alz.095388 |
Published in: | Alzheimer's & Dementia: The Journal of the Alzheimer's Association |
Language: | English |